Literature DB >> 27921309

Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.

M Sun1, C He1, W Wu1, G Zhou1, F Liu1, Y Cong2, Z Liu1.   

Abstract

Intestinal epithelial cells (IECs), an important barrier to gut microbiota, are subject to low oxygen tension, particularly during intestinal inflammation. Hypoxia inducible factor-1α (HIF-1α) is expressed highly in the inflamed mucosa of inflammatory bowel disease (IBD) and functions as a key regulator in maintenance of intestinal homeostasis. However, how IEC-derived HIF-1α regulates intestinal immune responses in IBD is still not understood completely. We report here that the expression of HIF-1α and IL-33 was increased significantly in the inflamed mucosa of IBD patients as well as mice with colitis induced by dextran sulphate sodium (DSS). The levels of interleukin (IL)-33 were correlated positively with that of HIF-1α. A HIF-1α-interacting element was identified in the promoter region of IL-33, indicating that HIF-1α activity regulates IL-33 expression. Furthermore, tumour necrosis factor (TNF) facilitated the HIF-1α-dependent IL-33 expression in IEC. Our data thus demonstrate that HIF-1α-dependent IL-33 in IEC functions as a regulatory cytokine in inflamed mucosa of IBD, thereby regulating the intestinal inflammation and maintaining mucosal homeostasis.
© 2016 British Society for Immunology.

Entities:  

Keywords:  HIF-1α; IL-33; inflammatory bowel disease

Mesh:

Substances:

Year:  2016        PMID: 27921309      PMCID: PMC5290230          DOI: 10.1111/cei.12896

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  HIF-1 and mechanisms of hypoxia sensing.

Authors:  G L Semenza
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

2.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.

Authors:  Luca Pastorelli; Rekha R Garg; Sharon B Hoang; Luisa Spina; Benedetta Mattioli; Melania Scarpa; Claudio Fiocchi; Maurizio Vecchi; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  IL-33 attenuates development and perpetuation of chronic intestinal inflammation.

Authors:  Philipp Groβ; Kristina Doser; Werner Falk; Florian Obermeier; Claudia Hofmann
Journal:  Inflamm Bowel Dis       Date:  2012-04-16       Impact factor: 5.325

Review 4.  Microbiota regulation of inflammatory bowel disease and colorectal cancer.

Authors:  Zhanju Liu; Anthony T Cao; Yingzi Cong
Journal:  Semin Cancer Biol       Date:  2013-09-23       Impact factor: 15.707

5.  Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.

Authors:  Pieter Hindryckx; Martine De Vos; Peggy Jacques; Liesbeth Ferdinande; Harald Peeters; Kim Olievier; Sara Bogaert; Brigitta Brinkman; Peter Vandenabeele; Dirk Elewaut; Debby Laukens
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

6.  miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.

Authors:  Chong He; Yan Shi; Ruijin Wu; Mingming Sun; Leilei Fang; Wei Wu; Changqin Liu; Maochun Tang; Zhong Li; Ping Wang; Yingzi Cong; Zhanju Liu
Journal:  Gut       Date:  2015-09-03       Impact factor: 23.059

Review 7.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.

Authors:  Dan Knights; Kara G Lassen; Ramnik J Xavier
Journal:  Gut       Date:  2013-10       Impact factor: 23.059

8.  IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

Authors:  Hui-Rong Jiang; Marija Milovanović; Debbie Allan; Wanda Niedbala; Anne-Galle Besnard; Sandra Y Fukada; Jose C Alves-Filho; Dieudonnée Togbe; Carl S Goodyear; Christopher Linington; Damo Xu; Miodrag L Lukic; Foo Y Liew
Journal:  Eur J Immunol       Date:  2012-06-12       Impact factor: 5.532

9.  Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis.

Authors:  Carole Peyssonnaux; Pilar Cejudo-Martin; Andrew Doedens; Annelies S Zinkernagel; Randall S Johnson; Victor Nizet
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.

Authors:  G T Furuta; J R Turner; C T Taylor; R M Hershberg; K Comerford; S Narravula; D K Podolsky; S P Colgan
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  12 in total

Review 1.  Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

Authors:  Ning Liu; Jintong Chen; Yinghua Zhao; Mingyue Zhang; Li Piao; Siqing Wang; Ying Yue
Journal:  Oncol Lett       Date:  2021-04-29       Impact factor: 2.967

2.  Irreversible effects of trichloroethylene on the gut microbial community and gut-associated immune responses in autoimmune-prone mice.

Authors:  Sangeeta Khare; Kuppan Gokulan; Katherine Williams; Shasha Bai; Kathleen M Gilbert; Sarah J Blossom
Journal:  J Appl Toxicol       Date:  2018-09-05       Impact factor: 3.446

3.  A decrease in IL-33 regulates matrix degradation and apoptosis in intervertebral disc degeneration via HIF-1alpha.

Authors:  Jinquan Hu; Qiang Yan; Hanran Jiang; Chen Xu; Yu Chen; Wen Yuan
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  Sam68 contributes to intestinal inflammation in experimental and human colitis.

Authors:  Wendy A Goodman; Shrikanth C Basavarajappa; Angela R Liu; Franklin D Staback Rodriguez; Tailor Mathes; Parameswaran Ramakrishnan
Journal:  Cell Mol Life Sci       Date:  2021-10-24       Impact factor: 9.207

Review 5.  Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease.

Authors:  Siyan Stewart Cao
Journal:  Gastroenterol Res Pract       Date:  2018-06-20       Impact factor: 2.260

Review 6.  IL-33-ST2 Axis in Liver Disease: Progression and Challenge.

Authors:  Zijian Sun; Binxia Chang; Miaomiao Gao; Jiyuan Zhang; Zhengsheng Zou
Journal:  Mediators Inflamm       Date:  2017-10-18       Impact factor: 4.711

Review 7.  Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.

Authors:  Hayandra Ferreira Nanini; Claudio Bernardazzi; Fernando Castro; Heitor Siffert Pereira de Souza
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742

8.  IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.

Authors:  Jie Liu; Wang Wang; Lei Wang; Shihao Chen; Bo Tian; Kewu Huang; Chris J Corrigan; Sun Ying; Wei Wang; Chen Wang
Journal:  EBioMedicine       Date:  2018-06-18       Impact factor: 8.143

9.  Intestinal Epithelial Cells-Derived Hypoxia-Inducible Factor-1α Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes.

Authors:  Lihua Sun; Teming Li; Hanlin Tang; Kun Yu; Yuanhang Ma; Min Yu; Yuan Qiu; Pengyuan Xu; Weidong Xiao; Hua Yang
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

10.  Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities.

Authors:  Jian Lin; Gengfeng Li; Chunjin Xu; Huiying Lu; Cui Zhang; Zhi Pang; Zhanju Liu
Journal:  Mediators Inflamm       Date:  2020-12-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.